Price Alert

Tenax Therapeutics Inc. (TENX)

NASDAQ: TENX · Real-Time Price · USD

5.90

-0.05 (-0.84%)

At close: Aug 15, 2025, 3:59 PM

5.97

1.19%

After-hours: Aug 15, 2025, 04:04 PM EDT

Tenax Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	105.46M	111.45M	94.85M	98.31M	9.38M	12.55M	9.79M	11.14M	13.39M	14.41M	2.12M	3.81M	7.23M	2.87M	5.58M	8.35M	1.67M	3.54M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	510.94K	494.88K
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	1.12K	1.12K	1.12K	1.12K	1.12K	1.12K	1.12K	9.55K	8.44K	8.44K	8.44K	8.44K	8.44K	8.44K	8.44K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	395K	88K	64K	33.88K	50.25K	66.63K	251.58K	267.08K	282.58K	304.58K	345.86K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	105.86M	112.06M	96.69M	99.78M	10.62M	14.46M	11.68M	11.88M	14.04M	15.26M	3.21M	4.51M	8.1M	3.46M	5.69M	8.58M	2.53M	4.52M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.71K	5.67K	5.63K	186.69K	216.99K	245.51K	273.51K	294.8K	319.93K	344.52K	34.53K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	1.12K	1.12K	1.12K	1.12K	5.82K	6.79K	6.75K	196.24K	225.43K	253.94K	281.95K	303.24K	328.37K	352.95K	42.96K
Total Assets	105.86M	112.06M	96.69M	99.78M	10.62M	14.46M	11.68M	11.89M	14.05M	15.27M	3.4M	4.74M	8.36M	3.74M	5.99M	8.91M	2.89M	4.56M
Account Payables	562K	1.84M	3.16M	1.58M	869.66K	1.08M	2.07M	134.79K	206.46K	172.03K	448.43K	265.41K	919.38K	1.29M	859.64K	776.25K	791.95K	997.44K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	278.8K	413.17K	500.9K	174.47K	345.75K	513.91K	624.3K	n/a	91.88K	228.76K	n/a	n/a	n/a	213.58K
Other Current Liabilities	2.53M	332K	1.34M	871.72K	160.58K	282.93K	236.88K	47.42K	41.63K	51.16K	245.39K	230.48K	81.85K	88.98K	n/a	118.37K	154.05K	107.44K
Total Current Liabilities	2.53M	2.77M	4.69M	2.56M	1.74M	2.03M	3.59M	602.21K	823.84K	983.86K	1.85M	689.82K	1.45M	1.98M	1.56M	1.46M	1.18M	1.43M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	31.08K
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	10K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	10K	64.2K	95.35K	125.88K	155.02K	183.59K	211.59K	239.04K	31.08K
Total Liabilities	2.53M	2.77M	4.69M	2.56M	1.74M	2.03M	3.59M	602.21K	823.84K	993.86K	1.91M	785.17K	1.57M	2.13M	1.75M	1.67M	1.41M	1.46M
Total Debt	n/a	n/a	n/a	n/a	278.8K	413.17K	500.9K	174.47K	345.75K	513.91K	807.89K	211.59K	330.91K	493.93K	290.78K	315.89K	340.5K	275.4K
Common Stock	n/a	n/a	n/a	341.00	196.00	196.00	30.00	2.39K	2.39K	2.18K	4.58K	3K	2.52K	2.52K	2.52K	2.52K	2.52K	1.5K
Retained Earnings	-336.11M	-325.26M	-314.86M	-308.59M	-304.63M	-301.05M	-297.25M	-294.03M	-292.06M	-290.95M	-289.54M	-286.99M	-284.08M	-281.22M	-278.49M	-275.28M	-271.48M	-269.77M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-0.00	n/a	-0.00	n/a	2.00	-274	-402
Shareholders Equity	103.33M	109.29M	91.99M	97.22M	8.88M	12.43M	8.1M	11.29M	13.22M	14.28M	1.49M	3.95M	6.78M	1.61M	4.24M	7.24M	1.47M	3.1M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	510.94K	494.88K